We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Ultrasensitive Droplet Biosensing Method Dramatically Shortens Identification Time for COVID-19

By LabMedica International staff writers
Posted on 30 Jul 2020
Print article
Image: Ultrasensitive Droplet Biosensing Method Dramatically Shortens Identification Time for COVID-19 (Photo courtesy of Virginia Tech)
Image: Ultrasensitive Droplet Biosensing Method Dramatically Shortens Identification Time for COVID-19 (Photo courtesy of Virginia Tech)
Scientists at Virginia Tech (Blacksburg, VA) have developed an ultrasensitive biosensing method that could dramatically shorten the amount of time required to verify the presence of the COVID-19 virus in a sample.

Currently, there is significant room to improve the pace of coronavirus testing. COVID-19 verification tests require a few hours to complete, as verification of the presence of the virus requires the extraction and comparison of viral genetic material, a time-intensive process requiring a series of steps. The amount of virus in a sampling is also subject to error, and patients who have had the virus for a shorter period of time may test negative because there is not enough of the virus present to trigger a positive result.

The Virginia Tech scientists have developed a method in which all the contents of a sampling droplet can be detected, and there is no extraction or other tedious procedures. The contents of a microdroplet are condensed and characterized in minutes, drastically reducing the error margin and giving a clear picture of the materials present. The key to this method is in creating a surface over which water containing the sample travels in different ways. On surfaces where drops of water may “stick” or “glide,” the determining factor is friction. Surfaces that introduce more friction cause water droplets to stop, whereas less friction causes water droplets to glide over the surface uninhibited.

The method starts by placing a collected sample into liquid. The liquid is then introduced into an engineered substrate surface with both high and low friction regions. Droplets containing sample will move more quickly in some areas but anchor in other locations thanks to a nanoantenna coating that introduces more friction. These stop-and-go waterslides allow water droplets to be directed and transported in a programmable and reconfigurable fashion. The “stopped” locations are very small because of an intricately placed coating of carbon nanotubes on etched micropillars.

These prescribed spots with nanoantennae are established as active sensors. The substrate surface is then heated so that the anchored water droplet starts to evaporate. In comparison with natural evaporation, this so-called partial Leidenfrost-assisted evaporation provides a levitating force which causes the contents of the droplet to float toward the nanoantenna as the liquid evaporates. The bundle of sample particles shrinks toward the constrained center of the droplet base, resulting in a rapidly-produced package of analyte molecules. For fast sensing and analysis of these molecules, a laser beam is directed onto the spot with the packed-in molecules to generate their vibrational fingerprint light signals, a description of the molecules expressed in waveforms. All of this happens in just a few minutes, and the fingerprint spectrum and frequency of the coronavirus can be quickly picked out of a lineup of the returned data. The Virginia Tech scientists are now pursuing a patent on the method, and are also pursuing funding from the National Institutes for Health to deliver the method for widespread use.

Related Links:
Virginia Tech

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing

Print article

Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: The HelioLiver Dx test has met the coprimary and secondary study endpoints in the CLiMB trial (Photo courtesy of Helio Genomics)

Blood-Based Test Outperforms Ultrasound in Early Liver Cancer Detection

Patients with liver cirrhosis and chronic hepatitis B are at a higher risk for developing hepatocellular carcinoma (HCC), the most prevalent type of liver cancer. The American Association for the Study... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Microbiology

view channel
Image: The POC PCR test shortens time for STI test results (Photo courtesy of Visby Medical)

POC STI Test Shortens Time from ED Arrival to Test Results

In a 2024 sexually transmitted infections (STIs) surveillance report by the World Health Organization (WHO), over 2.5 million cases were recorded, alongside a rise in the inappropriate use of antibiotics... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
LGC Clinical Diagnostics